Pearls in the management of acne: an advanced approach (Q33920818)

30 July 2017

1 reference

title

Pearls in the management of acne: an advanced approach (English)

1 reference

30 July 2017

Usatine RP

1

1 reference

PubMed ID

10815044

30 July 2017

Quan MA

series ordinal

2

1 reference

30 July 2017

1 June 2000

1 reference

Primary Care: Clinics in Office Practice

30 July 2017

1 reference

30 July 2017

27

1 reference

30 July 2017

2

1 reference

30 July 2017

289-308

1 reference

Acne fulminans treated with isotretinoin and "pulse" corticosteroids

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

A new topical retinoid--why a new topical acne therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

Long-term oral antibiotics for acne: is laboratory monitoring necessary?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

The Microsponge Delivery System (MDS): a topical delivery system with reduced irritancy incorporating multiple triggering mechanisms for the release of actives

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

1 reference

7 January 2021

Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

Evaluation of clinical efficacy and safety of adapalene 0Â·1% gel versus tretinoin 0Â·025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

Oral contraceptive failure rates and oral antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

Propionibacterium acnes colonization in acne and nonacne

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

Retinoic acid embryopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

The role of isotretinoin in the treatment of acne: personal observations

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

Therapy for acne vulgaris

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

Comparing 2.5%, 5%, and 10% benzoyl peroxide on inflammatory acne vulgaris.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

Oral isotretinoin treatment policy. Do we all agree?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

Report of the Consensus Conference on Acne Classification. Washington, D.C., March 24 and 25, 1990.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

Minocycline and Lupuslike Syndrome in Acne Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

Acne. A review of optimum treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

Acne vulgaris: a treatment update

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

Topical tretinoin in acne therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

Recurrence rates after the first course of isotretinoin

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2805%2970196-2

7 January 2021

10.1016/S0095-4543(05)70196-2

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10815044